Related Experiment Video
Updated: Aug 23, 2025

10:58
Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry
Published on: September 27, 2020
5.2K
Targeting Circuit Abnormalities in Neurodegenerative Disease
1Department of Neurology, University of Michigan, Ann Arbor, Michigan sharans@med.umich.edu.
Molecular Pharmacology
|October 30, 2022
Summary
Neurodegenerative diseases may be treated by targeting dysfunctional brain circuitry. Restoring proper electrical activity via ion channel modulation offers a promising therapeutic strategy for these complex disorders.
Area of Science:
- Neuroscience
- Neurology
- Pharmacology
Background:
- Neurodegenerative diseases are complex, with limited effective treatments despite advances in diagnosis and understanding of biological mechanisms.
- Current therapeutic strategies often focus on specific disease proteins or cells, limiting treatment efficacy.
Purpose of the Study:
- To propose reframing neurodegenerative diseases as conditions of dysfunctional circuitry.
- To highlight aberrant neuronal electrical activity (spiking) as a common downstream mechanism.
- To explore pharmacological targeting of ion channels for therapeutic intervention.
Main Methods:
- Review of existing literature on neurodegenerative disease mechanisms.
- Analysis of aberrant spiking as a common pathway.
- Evaluation of ion channel dysfunction in disease pathogenesis.
- Consideration of deep brain stimulation as a precedent for circuit modulation.
Main Results:
- Aberrant electrical spiking is a shared mechanism in many neurodegenerative diseases, often linked to ion channel dysfunction.
- Pharmacological targeting of ion channels presents a viable strategy for intervention.
- Restoring normal electrical activity could offer symptomatic and potentially disease-modifying benefits.
Conclusions:
- Viewing neurodegenerative diseases as circuitry disorders opens new therapeutic avenues.
- Targeting ion channels to correct aberrant electrical activity is a promising approach.
- This strategy may lead to novel treatments, alone or in combination with existing therapies.
Related Concept Videos
Neural Regulation
39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
Disorders of the Nervous Tissue
1.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.5K
Neural Circuits
1.4K
Neural circuits and neuronal pools are two of the main structures found in the nervous system. Neural circuits are networks of neurons that work together to carry out a specific task or process. They consist of interconnected neurons and glial cells, which provide structural and metabolic support.
Neuronal pools are collections of nerve cells with similar functions and interact through chemical and electrical signals. These pools include both interneurons (the central neural circuit nodes that...
Neuronal pools are collections of nerve cells with similar functions and interact through chemical and electrical signals. These pools include both interneurons (the central neural circuit nodes that...
1.4K
Parkinson's Disease: Overview
671
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
671
Alzheimer's Disease: Overview
626
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
626
Long-term Potentiation
2.9K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.9K

